Background: Protein disulfide isomerase (PDI), a multifunctional protein of the endoplasmic reticulum, catalyzes the formation, breakage and rearrangement of disulfide bonds during protein folding. Dissection of this protein into its individual domains has confirmed the presence of the a and a′ domains, which are homologous to thioredoxin, having related structures and activities. The a and a′ domains both contain a -Cys-Gly-His-Cys-active-site sequence motif. The remainder of the molecule consists primarily of two further domains, designated b and b′, which are thought to be sequence repeats on the basis of a limited sequence similarity. The functions of the b and b′ domains are unknown and, until now, the structure of neither domain was known.
Background
Protein disulfide isomerase (PDI) was the first proteinfolding catalyst to be discovered [1, 2] and appears to be the primary catalyst of protein folding involving disulfide bond formation in the eukaryotic endoplasmic reticulum [3, 4] . Although the function of PDI has been known for more than thirty years, its structure has not been determined; consequently, in contrast to other proteins that assist protein folding, many aspects of the mechanism of PDI action remain unknown. A major advance in the understanding of the structure and disulfide isomerase activities of PDI was the discovery by Edman et al. [5] that the primary structure of PDI contains two segments that are homologous both to each other (47% identity) and to thioredoxin. The thioredoxin fold is incorporated into a variety of proteins that catalyze the formation and reduction of disulfide bonds in other substrate proteins [6] . The active sites of these catalysts contain the motif -Cys-X-Y-Cys-, which cycles between the dithiol and disulfide forms during catalysis [7] . The disulfide bond of thioredoxin is stable and thus stabilizes the folded conformation of this protein [7, 8] ; however, the disulfide bonds of PDI and other thioredoxin-related proteins are unstable and destabilizing [9, 10] , as a result of differences in interactions with the thiol groups of the reduced forms [11] . Thus, thioredoxin reduces protein disulfide bonds, whereas the other related proteins catalyze the formation of these bonds [12] .
Until now, the structure and functions of only the thioredoxin-like a and a′ domains of PDI have been clearly elucidated. The middle section of the PDI sequence was interpreted by Edman et al. [5] to consist of two segments that are homologous to each other (but only 28% identical in part of their sequences) and these were termed the b and b′ domains. The domain structure of PDI ( Fig. 1) has recently been determined experimentally by a combination of protein engineering and limited proteolysis studies [13] . This structure confirms the original domain assignments of Edman et al. [5] , although with different domain limits (Fig. 1) , and rules out subsequently reported modifications [14] . The structure of the a domain has been confirmed as resembling that of thioredoxin [15] .
The a and a′ domains catalyze only a subset of the reactions catalyzed by PDI, which in particular includes those involved in forming protein disulfide bonds [16] . These domains are inefficient in the catalysis of disulfide rearrangements, especially in folding intermediates that contain substantial amounts of folded structure; their isomerase activity is dependent upon the presence of the b and b′ domains. Establishing the structures of the b and b′ domains is therefore an important step in understanding their functional contribution to the complete PDI molecule.
Results and discussion PDI b-domain folding topology
The global fold of the b domain has now been determined using multi-dimensional nuclear magnetic resonance (NMR) techniques. The protein studied consisted of residues 119-228 of mature human PDI [13] , and gave NMR spectra characteristic of a folded protein (Fig. 2 ). Assignments were accomplished using [ 15 N]-and [ 15 N plus 13 C]-labelled forms. The patterns of secondary structure present in the b domain were determined initially from chemical shift and nuclear Overhauser effect (NOE) data, which showed that the order of ␣ helices and ␤ strands in the sequence is The domain structure of human PDI. The domain boundaries have been determined by a combination of protein engineering and limited proteolysis studies ( [13] and unpublished observations). The first and last residues of each folded structure are indicated. The c domain at the carboxyl terminus comprises a 24 residue acidic segment in which over half the residues are glutamate or aspartate, followed by the KDEL (Lys-Asp-Glu-Leu) sequence for retention in the endoplasmic reticulum. The 1 H-15 N heteronuclear single quantum coherence (HSQC) spectrum of 13 between H N and H ␣ atoms gave the topology of the fivestranded ␤ sheet, ␤1-␤3-␤2-␤4-␤5, in which only ␤4 is antiparallel to the others. The three-dimensional fold of the backbone of the b domain was determined using 925 NMR restraints. A superposition of the backbones of the 10 structures with the lowest total energy of the ensemble of 20 structures calculated is shown in Figure  3 . Residues 120-217 were found in fixed, folded conformations, in agreement with the limits of the folded structure inferred from protection against limited proteolysis [13] .
Similarities with other structures
The structure of the b domain is very similar to that of thioredoxin and of other members of the family of thioredoxin-related proteins, including the PDI a domain (Fig. 4) [15] . Automated comparison of the b-domain structure with others in the protein structure database revealed that the structure was primarily similar to proteins containing the thioredoxin motif. The root mean square (r.m.s.) differences between the structures of human thioredoxin and of the a and b domains were 2.1 Å and 2.2 Å, respectively; the a and b domains were less Research Paper Protein disulfide isomerase b domain structure Kemmink et al. 241
Figure 3
Stereoview of the C␣ traces of the 10 structures used for analysis of the b domain generated from the NMR data. The 10 carboxy-terminal residues were disordered, and therefore only residues 119-218 are plotted. The structures were superimposed with respect to the backbone N, C ␣ and C′ atoms in the ensemble [40] .
Figure 4
MOLSCRIPT representations [41] of one of the structures of (a) the PDI a domain and of (b) the b domain (right) in the same orientation. The active-site disulfide bond of the a domain is depicted at the lower right as a ball-and-stick model.
(a) (b)
similar to each other, with an r.m.s. difference of 3.5 Å. Alignments of the primary structures of the a and b domains with human thioredoxin, based on their threedimensional structures, are presented in Figure 5 .
The close similarity of the three-dimensional structure of the PDI b domain to that of thioredoxin is surprising, as their primary structures are not detectably similar and no sequence homology has been reported previously. Alignment of the sequences of thioredoxin and the PDI a and b domains on the basis of their common structures (Fig. 5 ) also produces only minimal similarities. In terms of primary sequence, only four positions have the same amino-acid residue in all three sequences (Fig. 5) . Of the 110 residues of the b domain, only 17 are identical to human thioredoxin; in contrast, 30 are identical between thioredoxin and the PDI a domain. Nevertheless, the analysis of the primary structure of the b domain, using the procedure 'gonnet+predss' [17] (available at URL http://www.mbi.ucla.edu/people/frsvr/frsvr.html), identified the thioredoxin fold as being the most likely structure adopted by this domain.
Edman et al. [5] concluded that the segments corresponding approximately to the b and b′ domains were sufficiently similar in amino-acid sequence and secondary-structure propensities to allow one to conclude that they are homologous. These similarities are not totally convincing in themselves, but analysis of the b′ domain by the 'gonnet+predss' procedure also indicated that this domain is most likely to adopt the thioredoxin fold; this assignment is consistent with the spectral and physical properties of the b′ domain (our unpublished observations).
Modular structure of PDI
The finding that the individual a, a′, b and b′ domains of PDI have folded structures that are stable in isolation indicates that PDI has a modular structure [18] . Moreover, the stabilities of these modules appear to be similar whether the modules are in isolation or found within the intact PDI molecule [13] , demonstrating that these relatively independent modules share few stabilizing interactions in the intact PDI molecule.
It is therefore likely that all four of the PDI modules arose by partial gene duplication or shuffling of a common thioredoxin ancestral gene, followed by divergence [18] . The absence of detectable amino-acid sequence similarities in the b and b′ modules, in contrast to a and a′, presumably is a result of both the length of time since the gene duplication event and greater evolutionary pressures for change; the b and b′ modules have changed more rapidly than a and a′ amongst the known PDI sequences. All four modules probably arose before the appearance of most eukaryotic species, because homologous PDI sequences are present in eukaryotes as diverse as mammals, yeast and plants. All of these eukaryotic PDIs have recognizable a and a′ modules [19] ; the putative b and b′ modules have diverged so much between species that it is not certain that they are all homologous, but the corresponding segments always contain approximately the same number of amino acids.
There are recognizable a, a′ and b sequences in the ERp60 and ERp72 homologues of PDI [20, 21] , suggesting that they arose from the same ancestor as PDI; in the case of ERp72, a further gene-shuffling event has added another thioredoxin-like module to the amino terminus [21] . Thus, PDI demonstrates that modular proteins arose in the distant past, in contrast to the common belief that such modular evolution is a recent phenomenon. Adjacent homologous modules might tend to be more apparent in recently diverged proteins if the modules merge structurally to become a single module during evolutionary divergence. PDI might be an exception to this proposition because its modular structure has been retained during evolution.
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Figure 5
Sequence alignments of the human PDI a and b domains and of thioredoxin (hTRX), based on their structures. The alignments were made using the program DALI [42] and the FSSP database [43] . The aligned residues occur in the same spatial positions in the structures; a dash indicates that there was no homologous residue. The numbers above the sequences correspond to the numbering of the amino acids in the PDI b domain. The four residues that are identical in all three sequences are indicated with asterisks. The residues present in ␤ strands are red and those in ␣ helices are blue. The -Cys-X-Y-Cysactive site of hTRX and of the PDI a domain is boxed. 
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Function of the b and b¢ domains
Addition of the b and b′ modules to the a or a′ modules gradually increases the disulfide isomerase activity of PDI (our unpublished observations). This is likely to result from the binding of the b and b′ modules to substrate proteins, because many thioredoxins have well-characterized peptide-binding sites [22] [23] [24] . The multiple thioredoxin modules of PDI may provide multiple sites of contact with substrate proteins. As PDI has also been identified as the ␤ subunit of prolyl 4-hydroxylase [25] and as one of the two subunits of the microsomal triglyceride transfer protein complex [26] , the various PDI modules may also be involved in these additional activities.
The b and b′ modules appear to have lost the thioredoxin function of catalyzing thiol-disulfide exchange reactions (they have no detectable activity; our unpublished observations). Neither module contains the two cysteine residues that are normally found at the active site of thioredoxin, and, in fact, the active site appears to have been deleted from the b domain (Fig. 5) . Other residues that normally contribute to the catalytic activity of thioredoxin, such as Asp26, Trp31 and Pro75 of human thioredoxin, which are conserved in the a and a′ modules, have all been replaced in the b and b′ modules. On the other hand, the thioredoxin-like modules of PDI have not incorporated any substantial insertions like those that have occurred in other members of the family of thioredoxinrelated molecules, some of which have extra domains of up to 76 residues inserted at surface positions within the thioredoxin motif [6] .
The thioredoxin motif has clearly been adapted considerably in the PDI b and b′ modules. Examples of less extreme functional adaptations are known in PDI homologues in which segments with detectable homology to thioredoxin have lost one of the two active-site cysteine residues [27] . The enzyme glutathione peroxidase has a thioredoxin motif, but the accessible cysteine residue has been changed to a selenocysteine, and the second cysteine residue has been replaced with threonine [28] . Glutathione S-transferase also has a thioredoxin motif, but with no cysteine-type residues at its active site; nevertheless, this enzyme binds to the cysteine residue of its substrate, glutathione, at a position corresponding to the accessible cysteine of thioredoxin [29] . Thus, the absence of cysteine residues does not rule out the possibility that the b or b′ modules may act on thiol and disulfide groups, although no such activities have been detected so far. The PDI b module also has significant homology to the calciumbinding protein calsequestrin [13] , which would appear to be an extreme adaptation of the thioredoxin fold.
Conclusions
The folds of two domains of PDI have now been determined experimentally. As expected on the basis of sequence homology, the PDI a domain, which includes the -Cys-Gly-His-Cys-active-site sequence, adopts a fold very similar to that of thioredoxin [15] . Despite the absence of any significant sequence similarity to the a domain or to thioredoxin, the 'non-catalytic' PDI b domain also adopts the same fold. The structures of the other two PDI domains -the a′ and b′ domains -have yet to be solved. The PDI a′ domain is obviously an internal repeat of the a domain (because they share 47% sequence identity) and will almost certainly have the same fold. The degree of sequence identity between the b and b′ domains is not sufficiently extensive to be certain that they are internal repeats, but, nevertheless, there are indications that the b′ domain adopts a thioredoxin-like fold. The a and a′ domains of PDI contain the active site and can catalyze a subset of reactions catalyzed by intact PDI [10, 16] . However, the non-catalytic b and b′ domains appear to be important for the disulfide rearrangement activity of PDI, and possibly also its other enzymatic roles. These properties cannot be attributed simply to single domains, but most probably involve an interplay between the different thioredoxin-like modules of PDI. Structural studies of all of the PDI modules and of multi-domain constructs will be essential in order to explain the full spectrum of PDI activities.
Materials and methods
Materials and sample preparation
The b domain (residues 119-228) of human PDI was prepared as described previously [13] . The methods to produce the [ 15 N]-and [ 15 N plus 13 C]-labelled forms were similar to those used previously for the PDI a domain [15, 30] . The proteins were dissolved to concentrations of 1-2 mM in 93% 1 H 2 O/7% 2 H 2 O (v/v) containing 10 mM sodium phosphate buffer at pH 6.5.
NMR spectroscopy
All NMR spectra were recorded at 300 K on a Varian Unity INOVA 600 spectrometer, except for the 15 N-resolved three-dimensional NOESY experiment, which was recorded on a Bruker AMX600 spectrometer. Both spectrometers were equipped with triple-resonance z-gradient probes. The 1 H, 13 C␣, and 15 N backbone resonances of the PDI b domain were assigned from CBCANH, CBCA(CO)NH, and HBHA(CBCACO)NH triple-resonance experiments [31, 32] . Assignment of the sidechains also used HC(C)H-TOCSY and H(C)CH-COSY experiments [33, 34] .
Collection of structural data
A total of 850 intraresidue and interresidue proton-proton NOEs (Table 1) were obtained from the analysis of 13 C-and 15 N-separated three-dimensional NOESY experiments recorded with a mixing time of 100 ms. Vicinal 3 J HNH␣ -coupling constants were measured using a three-dimensional HNHA experiment [35] . A number of first sidechain dihedral angles 1 , together with ␤-methylene proton stereospecific assignments, were determined by estimation of 3 J H␣H␤ -and 3 J NH␤ -coupling constants, using a three-dimensional 15 N-TOCSY-HSQC experiment recorded with a short coherence mixing time (30 ms) [36] , and a three-dimensional HNHB experiment [37] , respectively.
Structure calculations
Structures of the polypeptide backbone were calculated using X-PLOR [38] . Distance restraints were classified according to their observed intensities in the NOESY spectra as strong (0.18-0.25 nm), medium (0.18-0.35 nm) or weak (0.18-0.50 nm). The calculations were based on a total of 850 proton-proton distance restraints, of which 324 were intraresidue, 307 sequential, 103 between residues separated in the sequence by 1-3 residues, 103 more than 3 residues apart, and 13 ambiguous (Table 1 ). In the calculations, 52 dihedral angle restraints were used. The angle was restrained to -60 (± 30)° if 3 J HNH␣ < 5 Hz or to -120 (± 30)° if 3 J HNH␣ > 8 Hz. Depending on the relative values of 3 J H␣H␤ and 3 J NH␤ (see above), 23 1 dihedral angles were restrained to -60 ( ±30)°, 60 ( ±30)° or 180 ( ±30)°. First, 50 structures were generated using a hybrid distance-geometry/simulated-annealing approach [39] . Subsequently, from this initial set, 20 structures with the lowest total energy were selected for further rounds of refinement using simulated annealing. Finally, an ensemble of the 10 structures with the lowest total energy was used for structural analysis. The coordinates of the final 10 structures representing the PDI b domain will be made available on the World Wide Web server of the European Molecular Biology Laboratory (URL http://www.nmr.embl-heidelberg.de). 
